Arizona State University

Home>Tag: Arizona State University
Sep 8 2020

Halberd Corporation Research on Covid-19 Treatment Development Begins at ASU

By |2020-09-08T11:19:17-04:00September 8th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 8, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced Arizona State University (ASU) commenced its research work for Halberd Corp. The initial phases of ASU’s research focuses on the development of antibodies in support of Halberd’s two issued patents and three Covid-19 related provisional patent applications for extracorporeal removal of ...

Sep 2 2020

Why Halberd Corporation Selected ASU And Where They Stand Among Other Universities

By |2020-09-02T08:00:19-04:00September 2nd, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 2, 2020 – Halberd Corporation (OTC PINK: "HALB") today revealed why they selected Arizona State University (ASU) to conduct sponsored research to develop a Covid-19 treatment. ASU is one of the fastest growing research universities in the country and ranks among the top 10 for Department of Health and Human Services ...

Aug 31 2020

Halberd Selects Arizona State University (ASU) to Develop Its Patented Covid-19 Treatment(s)

By |2020-08-31T08:00:31-04:00August 31st, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, August 31, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced the signing of a development agreement with Arizona State University (ASU) to conduct sponsored research to develop Halberd’s Covid-19 treatments.  The work will focus on developing antibodies in support of Halberd’s two issued patents and three Covid-19 related provisional patent applications ...

Go to Top